Lower-Limb Exoskeleton Technology for Non-Ambulatory Individuals With Spinal Cord Injury
NCT ID: NCT07128901
Last Updated: 2025-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
6 participants
INTERVENTIONAL
2026-01-01
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study participants will complete 5 walking sessions and 2 test sessions with two different exoskeleton devices in a randomized order. During each test session, data will be collected using motion sensors, portable metabolic monitors, and muscle sensors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Self-balancing lower limb exoskeleton
Participants will use the self-balancing lower limb exoskeleton for 5 walking sessions and then complete a test session.
Wandercraft Atalante X
Self-balancing lower limb exoskeleton
User-balancing lower limb exoskeleton
Participants will use the user-balancing lower limb exoskeleton for 5 walking sessions and then complete a test session.
Ekso Indego Therapy
User-balancing lower Limb exoskeleton
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ekso Indego Therapy
User-balancing lower Limb exoskeleton
Wandercraft Atalante X
Self-balancing lower limb exoskeleton
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Motor-complete (ASIA Impairment Scale classification A/B)
* Injury level T3-T10
* Age 18-70 yrs
* Height between 5'1" and 6'1"
* Weight \<200 lbs (90kg)
* Seated hip width \< 42cm
* Standing tolerance \> 15mins
* Have sufficient upper limb strength to use a platform rolling walker, rolling walker, or forearm crutches
* Currently medically cleared and enrolled in the Shepherd Center Beyond Therapy program
* Medically cleared for weight-bearing activities
* Able to follow directions to safely participate in assessments
Exclusion Criteria
* Hip or knee contracture \> 10 degrees or ankle contracture \> 5 degrees
* Severe or uncontrolled spasticity
* Non-healing fractures
* Uncontrolled autonomic dysreflexia
* Heart or peripheral vascular condition
* Pregnancy
* Active heterotopic ossification
* Active deep vein thrombosis
* Cognitive deficits that make it difficult for participants to follow verbal instructions or making it unsafe to participate in assessments.
* Any reason the principal investigator feels the potential participant may not be safe to participate in the study
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shepherd Center, Atlanta GA
OTHER
Georgia Institute of Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maegan Tucker
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Shepherd Center
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Maegan Tucker, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2331046-1
Identifier Type: -
Identifier Source: org_study_id